Evidence map›Paper›PMID 34668840›Full record

ArticleAmerican journal of respiratory cell and molecular biology2022

Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects against Pulmonary Fibrosis.

Irina G Luzina, Violeta Rus, Virginia Lockatell, Jean-Paul Courneya, Brian S Hampton, Rita Fishelevich, Alexander V Misharin, Nevins W Todd, Tudor C Badea, Horea Rus and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  12. Article
  13. Article
  14. Pumping the Brakes on Pulmonary Fibrosis: A New Role for Regulator of Cell Cycle.American journal of respiratory cell and molecular biology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Irina G LuzinaUniversity of Maryland School of Medicine, Baltimore, Maryland.
Violeta RusUniversity of Maryland School of Medicine, Baltimore, Maryland.
Virginia LockatellUniversity of Maryland School of Medicine, Baltimore, Maryland.
Jean-Paul CourneyaHealth Sciences and Human Services Library, University of Maryland-Baltimore, Baltimore, Maryland.
Brian S HamptonUniversity of Maryland School of Medicine, Baltimore, Maryland.
Rita FishelevichUniversity of Maryland School of Medicine, Baltimore, Maryland.
Alexander V MisharinDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, Illinois.
Nevins W ToddUniversity of Maryland School of Medicine, Baltimore, Maryland.
Tudor C BadeaRetinal Circuits Development and Genetics Unit, National Eye Institute, Bethesda, Maryland; and.
Horea RusUniversity of Maryland School of Medicine, Baltimore, Maryland.
Sergei P AtamasUniversity of Maryland School of Medicine, Baltimore, Maryland.
University of Maryland, Baltimore · USBaltimore VA Medical Center · USNational Eye Institute · USNorthwestern University · US

Funding

Tissue resident macrophages regulate proteostasis in the aging lungP01AG049665 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GR Scott Budinger · 2015 to 2026
$26.9M
Taming IL-33 to Control Inflammation and FibrosisR01AR077562 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI LUZINA, IRINA G. · 2021 to 2025
$1.7M
The Mechanisms of Profibrotic Sensitization by IL33R01HL126897 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI LUZINA, IRINA G. · 2015 to 2018
$1.4M
The Central Role of IL-33 in Immune-Mediated ScarringI01BX002499 · VA · BALTIMORE VA MEDICAL CENTER · PI LUZINA, IRINA G. · 2015 to 2020
–
BLRD VA I01 BX002499National Institutes of Health (NIH) R01AR077562NHLBI NIH HHS R01 HL126897NHLBI NIH HHS R01HL126897NIAMS NIH HHS R01 AR077562NIA NIH HHS P01 AG049665
6 · The paper itself

Abstract

Some previous studies in tissue fibrosis have suggested a profibrotic contribution from elevated expression of a protein termed either RGCC (regulator of cell cycle) or RGC-32 (response gene to complement 32 protein). Our analysis of public gene expression datasets, by contrast, revealed a consistent decrease in RGCC mRNA levels in association with pulmonary fibrosis. Consistent with this observation, we found that stimulating primary adult human lung fibroblasts with transforming growth factor (TGF)-β in cell cultures elevated collagen expression and simultaneously attenuated RGCC mRNA and protein levels. Moreover, overexpression of RGCC in cultured lung fibroblasts attenuated the stimulating effect of TGF-β on collagen levels. Similar to humans with pulmonary fibrosis, the levels of RGCC were also decreased

Indexed as

AnimalsCell CycleCells, CulturedFemaleFibroblastsHumansLungMiceMice, Inbred C57BLNuclear ProteinsPhosphorylationPulmonary FibrosisSmad2 ProteinTranscriptomeTransforming Growth Factor beta3Nuclear ProteinsRgc-32 protein, mouseSmad2 ProteinSmad2 protein, mouseTgfb3 protein, mouseTransforming Growth Factor beta3idiopathic pulmonary fibrosislung fibrosisregulator of cell cycle proteinresponse gene to complement 32 proteinscleroderma lung disease

Identifiers

PMID34668840
PMCPMC8845131
OpenAlexW3207178866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.